PUBLIC PREFERENCES FOR ORPHAN DRUG FUNDING: RESULTS OF SUBGROUP ANALYSES

被引：0
|
作者：
Korchagina, D.
Aballea, S. [1 ]
Millier, A. [1 ]
Thokagevistk, K. [1 ]
Toumi, M. [2 ]
机构：
[1] Creativ Ceut, Paris, France
[2] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.853
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY39
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [41] Moving beyond the Court of Public Opinion: A Citizens' Jury Exploring the Public's Values around Funding Decisions for Ultra-Orphan Drugs
    Stafinski, Tania
    Street, Jacqueline
    Young, Andrea
    Menon, Devidas
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 (01)
  • [42] Enzyme replacement therapy "drug holiday": Results from an unexpected shortage of an orphan drug supply in Australia
    Goldblatt, Jack
    Fletcher, Janice M.
    McGill, Jim
    Szer, Jeffrey
    Wilson, Meredith
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (01) : 107 - 110
  • [43] EXAMINATION OF PATIENT PREFERENCES: SUBGROUP COMPARISONS OF TIME TRADE-OFF AND STANDARD GAMBLE RESULTS
    Iskedjian, M.
    Navarro, V
    Farah, B.
    Berbari, J.
    Walker, J. H.
    Le Lorier, J.
    VALUE IN HEALTH, 2013, 16 (03) : A37 - A37
  • [44] PUBLIC FUNDING FOR PARTIALLY HOSPITALIZED DRUG AND ALCOHOL ABUSERS - PSYCHIATRIC NOSOLOGY AT THE NADIR
    RINELLA, VJ
    INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 1980, 3 (03) : 311 - 318
  • [45] Extramural research at the National Institute on Drug Abuse: Funding, interests, and public policy
    Rogers, JM
    JOURNAL OF DRUG ISSUES, 2000, 30 (03) : 621 - 639
  • [46] Funding the new biologics - Public policy issues in drug formulary decision making
    Lewis, S
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2002, 16 (12): : 869 - 872
  • [47] Social Values and Public Policy on Cancer Drug Funding Decisions for Children in Canada
    Denburg, A.
    Giacomini, M.
    Ungar, W.
    Abelson, J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S418 - S419
  • [48] EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
    L. Schmidt
    O. Sehic
    C. Wild
    Journal of Pharmaceutical Policy and Practice, 14
  • [49] EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
    Schmidt, L.
    Sehic, O.
    Wild, C.
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [50] Public preferences for the return of research results in genetic research: a conjoint analysis
    Bollinger, Juli Murphy
    Bridges, John F. P.
    Mohamed, Ateesha
    Kaufman, David
    GENETICS IN MEDICINE, 2014, 16 (12) : 932 - 939
12345